LOCKHEED MARTIN INVESTMENT MANAGEMENT CO

Position in JNJ — Johnson & Johnson

CIK 897599 BETHESDA, MD

Position in JNJ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$43,482,203

-$15,354,505 QoQ

Shares Held

171,210

-28.9% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

2.30%

of 13F equity value

Holder Rank

#476

of 4,663 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds $85,820,334 across 7 Drug Manufacturers - General names. JNJ ranks #1 (50.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	171,210	$43,482,203
2	LLY	ELI LILLY & Co	13,090	$15,700,540
3	ABBV	AbbVie Inc.	41,130	$10,349,953
4	NVS	Novartis AG	48,400	$7,585,248
5	MRK	Merck & Co., Inc.	32,500	$4,176,250
6	GILD	Gilead Sciences, Inc.	24,100	$3,044,794
7	NVO	Novo Nordisk A S	30,900	$1,481,346

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$43,482,203	171,210	-28.9%	Shares	Sole	2026-08-12
2026-03-31	$58,836,708	240,700	-5.3%	Shares	Sole	2026-05-07
2025-12-31	$52,590,134	254,120	+5.1%	Shares	Sole	2026-02-05
2025-09-30	$44,816,014	241,700	+13.2%	Shares	Sole	2025-10-30
2025-06-30	$32,627,400	213,600	+247.3%	Shares	Sole	2025-08-04
2025-03-31	$10,199,160	61,500	-44.1%	Shares	Sole	2025-05-12
2024-12-31	$15,922,662	110,100	-6.5%	Shares	Sole	2025-01-27
2024-09-30	$19,074,462	117,700	+143.7%	Shares	Sole	2024-11-14
2024-06-30	$7,059,528	48,300	-53.5%	Shares	Sole	2024-08-07
2022-12-31	$18,334,503	103,790	-1.6%	Shares	Sole	2023-02-14
2022-09-30	$17,237,747	105,520	-17.1%	Shares	Sole	2022-11-03
2022-06-30	$22,582,822	127,220	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.